Shares of Sanofi SA (SNYNF) were gaining around 2 percent in Paris trading after the French drug maker reported higher profit in its first quarter with strong sales growth mainly from Dupixent, as well as COVID-19 impact. Looking ahead for fiscal 2020, Sanofi continues to expect business earnings per share to grow around 5 percent at constant exchange rates.
from RTT - Earnings https://ift.tt/3bGg8k4
via IFTTT
No comments:
Post a Comment